Skip to main content
Account

Peer review reports

From: A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer

Original Submission
7 Jan 2020 Submitted Original manuscript
5 Feb 2020 Reviewed Reviewer Report - Takashi Sasaki
19 Feb 2020 Author responded Author comments - Ayhan Ulusakarya
22 Mar 2020 Reviewed Reviewer Report - Changhoon Yoo
6 Apr 2020 Author responded Author comments - Ayhan Ulusakarya
Resubmission - Version 2
19 Feb 2020 Submitted Manuscript version 2
10 Apr 2020 Author responded Author comments - Ayhan Ulusakarya
Resubmission - Version 3
10 Apr 2020 Submitted Manuscript version 3
15 Apr 2020 Author responded Author comments - Ayhan Ulusakarya
Resubmission - Version 4
15 Apr 2020 Submitted Manuscript version 4
Publishing
16 Apr 2020 Editorially accepted
3 Jun 2020 Article published 10.1186/s12885-020-07004-y

Learn about peer review

Back to article page

Navigation